|
SPECIAL REPORT
A pharmacy professor from the University of Kentucky has developed a quicker, easier way to deliver naloxone via a nasal spray, and his invention is being fast-tracked by the Food and Drug Administration, according to a report in the Lexington Herald-Leader. Professor Daniel Wermeling’s invention is in the final round of clinical trials and could be available as early as next year.
|
"The goal is to make the medication available to patients at high risk of opioid overdose and to caregivers, including family members, who may lack specialized medical training."
— Daniel Wermeling |
Like
Tweet
